Developmental commitment involves activation of lineage-specific genes, stabilization of a lineagespecific gene expression program, and permanent inhibition of inappropriate characteristics. To determine how these processes are coordinated in early T cell development, the expression of T and B lineage-specific genes was assessed in staged subsets of immature thymocytes. T lineage characteristics are acquired sequentially, with germ-line T cell antigen receptor-␤ transcripts detected very early, followed by CD3 and terminal deoxynucleotidyl transferase, then pT␣, and finally RAG1. Only RAG1 expression coincides with commitment. Thus, much T lineage gene expression precedes commitment and does not depend on it. Early in the course of commitment to the T lineage, thymocytes lose the ability to develop into B cells. To understand how this occurs, we also examined expression of well defined B lineage-specific genes. 
In the mammalian hematopoietic system, cells differentiating from the same precursor can adopt any of multiple distinct developmental fates. Choice of a developmental lineage involves the activation of lineage-appropriate genes and the repression, or blocking of induction, of inappropriate genes. Many specific genes have been identified that characterize particular hematopoietic cell types, and the expression of these genes has begun to provide useful landmarks for hematolymphoid differentiation (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . However, the mechanism of lineage specification and the ''commitment'' events that make it irreversible still are not well understood at the level of the control of lineage-specific gene expression. One major question is whether ''master switch'' events exist, in which cellular identity is established by turning on a set of lineage-specific genes coordinately. Another major question is whether cells can activate such lineage-specific genes, yet still keep the option of following other developmental pathways. These unanswered questions cast shadows over attempts to infer the timing and mechanism of developmental commitment from the timing of activation of particular lineage-specific genes.
To address these issues we have focused on early murine T cell differentiation. In this system there are substantial data to establish a succession of lineage-restriction events, when developmental potential is narrowed, and to define their timing relative to defined phenotypic changes (11, 12) . We have used this system to investigate, first, which T cell-specific genes are activated at key stages of commitment, and second, when the cells lose the ability to express ''inappropriate'' genes. Our results show that T lineage genes are activated noncoordinately, that many of these genes are activated before commitment, that at least one B lineage gene is also activated during T lineage differentiation, and that repression of such inappropriate genes can occur long after the cells are committed.
MATERIALS AND METHODS

Cell Preparation and Reverse Transcriptase-PCR (RT-PCR)
Conditions. All thymocytes were obtained from animals between 3.5 and 5.5 weeks old and stained as described (13) . Stained cells, 5-20 ϫ 10 4 per selected population, were sorted into chilled tubes containing Hanks' balanced salt solution without phenol red, with 0.25% BSA, 5% fetal bovine serum, and azide. A portion of each sorted sample was reserved for reanalysis, and the rest of the cells were spun down, carrier tRNA was added, and first-strand cDNA was synthesized from each sample in a 40-l reaction as described (13) .
Primer pairs and annealing temperatures for the RT-PCRs were taken from the following references: HPRT (14); RAG-1, Ig-␣, 5, and terminal deoxynucleotidyltransferase (TdT) (1); CD3 (15); T cell antigen receptor-C␤ (TCR-C␤) (16) ; pT␣ (17) ; I (18); 0 and Ig-␤ (7). All amplification products cross an exon boundary. Different sample inputs were normalized to obtain matched signals with hypoxanthine phosphoribosyltransferase primers at a limiting number of cycles. Amplification was for 29-35 cycles (usually 35) in the experiments shown, and each lane shows the product amplified from Ϸ1% of the cells in the initial sample. Repeated analyses with various primers at lower and higher PCR cycle numbers were routinely used to verify relative levels of expression in different populations. The identity of the Ig-␤ PCR product (nucleotides 194-688), was confirmed by hybridization with an end-labeled internal oligonucleotide (nucleotides 571-591). Hybridization (at 20-25 cycles) was quantitated by PhosphorImager (Molecular Dynamics).
Fetal Liver and Spleen Cell Fractionation. C57BL͞6 fetal liver samples were obtained at E14.5 and stained with antibodies against B220 (CD45R, RA3-6B2), Sca-1 (Ly-6A, E13-161.7), and Gr-1 (Ly-6G, RB6-8C5), all from PharMingen. Preparative cell sorting with three-color flow cytometry was used to enrich four populations: (i) the B220 majority population (Ϸ92% of the population was in triple negative quadrants; 66% within sorting gate); (ii) the B220 thymocytes were stained, after Fc receptor blocking, with phycoerythrin-conjugated anti-CD4 (Becton Dickinson Labware), biotin conjugated anti-CD8 (Becton Dickinson Labware), and Streptavidin-RED670 (Life Technologies, Gaithersburg, MD), as well as fluorescein isothiocyanate antibodies against either HSA (sort 1) (CD24, PharMingen) or CD69 (sort 2) (PharMingen). Sorting gates are shown in Fig. 4 (sort 1, B ; sort 2, C). Cells were sorted by using single or double two-color gates depending on the markers used. Only the CD4 
RESULTS
Ordered Induction of T Lineage Genes Before Lineage Commitment. Expression of both lineage-appropriate and lineage-inappropriate genes was monitored by RT-PCR analysis of RNA from defined subsets of immature thymocytes. To obtain the cells in high enrichment, in most cases the starting thymocyte populations were taken from immunodeficient scid͞scid and RAG2 Ϫ͞Ϫ mice and sorted by multiparameter flow cytometry, as described in detail (13) . The developmental potentials of the equivalent populations of normal thymocytes have been studied extensively by cell transfer and in vitro culture approaches (reviewed in refs. 11 and 12) , and all interpretations in this report of their relative progress toward T lineage commitment are based on that body of work. Three main populations were examined, as shown in Fig To control for biological variation, all conclusions are based on parallel analyses of corresponding subpopulations from different strains of scid͞scid mice and from RAG2 Ϫ͞Ϫ mice. Fig. 2 shows that T lineage genes begin to be expressed noncoordinately in these cell types. RAG1 RNA was expressed only in the HSA ϩ subpopulations (Fig. 2 A) , as expected because only at this stage does TCR gene rearrangement normally begin (20) . Expression of CD3 and TdT begins earlier, because these were observed in HSA ϩ cells and, at lower levels, in the HSA Ϫ Sca-1 ration for expression, so only TCR␤ enhancer activity is relevant). TCR-C␤ transcripts also were the only T cell-specific genes detectable in fractions from normal E14.5 fetal liver, as shown in Fig. 2B . TCR-C␤ transcripts were expressed both in a fetal liver fraction enriched for B, T, and NK progenitors (fraction ''L,'' Sca-1 ϩ B220 (Fig. 2B, lane 7) . Some RAG1 expression also was seen in the fetal liver ''L'' fraction ( Fig. 2 A, lane 11) , but this appears to be because of B lineage precursors therein. The lack of any CD3 expression in these populations shows that T lineage differentiation in E14.5 fetal liver does not proceed even to the level of the earliest thymocytes.
These results suggest that TCR␤ germ-line transcription is activated first in lymphoid precursors, followed by CD3 and TdT, then pT␣, and last by induction of RAG1. The expression of pT␣ and TdT seems to be excluded or down-regulated in the NK-like HSA Ϫ Sca-1 Ϫ population (''B''), and RAG1 expression is induced only in those cells that have reached the HSA ϩ stage (''C͞D''). Some expression is precocious: at least two T lineage-specific genes, TCR␤ and CD3, clearly begin to be expressed before the stages (CD25 ϩ CD44 ϩ͞Ϫ ; here, population ''C'' in the HSA ϩ fraction) when the population is committed to give rise to T cells (25) (26) (27) (28) .
Selective Ectopic Expression of a B Lineage Gene. B cell developmental potential is reported to persist in the "CD4 low " class of immature thymocytes (25, 26, 28) , which consists of cells in a continuum from the HSA Ϫ Sca-1 ϩ fraction to the HSA ϩ fraction (29) (H.W., unpublished results; see Fig. 1 ). However, the B cell genes 5 and Ig-␣ (mB-1, CD79a), which were detected readily in the Sca-1 ϩ B220 ϩ fetal liver fraction, were undetectable in most of the thymocyte subsets (Fig. 2 A) . A slight signal for Ig-␣ expression was observed only in the minor, poorly characterized HSA ϩ Sca-1 Ϫ fraction (data not shown), possibly because of the presence of a minor population of thymic B cell precursors (30) . The absence of Ig-␣ and 5 expression initially suggested that the highly immature HSA Ϫ Sca-1 ϩ thymocytes (population ''A'') do not express any B lineage genes, even though they may be competent to undergo B lineage differentiation. However, as representatives of even earlier B lineage genes (1, 7, 18) , expression of the germ-line IgH transcripts 0 and I and of Ig-␤ (B29, CD79b) was also monitored (Fig. 2 A) . The primer pairs used for Ig-␤ detect the full-length mRNA, not the deleted form (31, 32) .
Unlike Ig-␣ and 5, these three transcripts were detected in thymocytes, describing distinct patterns of expression. The 0 amplification product was generated only from the most immature, HSA Ϫ Sca-1 ϩ cells (''A''), whereas the I product (generally considered B lineage-specific) was found in both subsets of HSA Ϫ cells (''A'' and ''B''). Both of these transcripts, however, were shut off during the transition from HSA Ϫ to HSA ϩ (Fig. 2 A and data not shown) . Thus, the germ-line transcription of the IgH locus does initiate in thymocytes, but is repressed during or before the induction of RAG1. Like these transcripts, Ig-␤ was also found to be expressed in the HSA Ϫ Sca-1 ϩ thymocytes (Fig. 2 A) . Unexpectedly, however, Ig-␤ was also found in the more advanced HSA ϩ thymocytes (populations ''C'' and ''D''), which correspond in phenotype (CD44 ϩ͞Ϫ CD25 ϩ ) to normal immature thymocytes that have completely lost any B cell developmental potential (25, 26, 28) . Only the HSA Ϫ Sca-1 Ϫ thymocytes (''B'') expressed this gene at lower levels.
Ig-␤ initially was reported to be expressed only in B lineage cells, and absent from thymocytes, by the criterion of slot-blot hybridization (33) . To confirm that genuine Ig-␤ was being detected with our primers, normal adult tissues were tested to verify specificity of expression (Fig. 3) , and the PCR products were hybridized with a third, labeled oligonucleotide representing an internal Ig-␤ sequence (Fig. 3B) . Although expression was abundant in normal spleen (Fig. 3A, lanes 3 and 6) , no product could be amplified from skeletal muscle cDNA (lane 1; Ϸ10 2 ϫ less, by hybridization), and much less Ig-␤ could be detected in cDNA from T enriched normal spleen cells (Fig. 3A, lane 2; Fig. 3B, lane 3) . In pure populations of T cells isolated by fluorescence-activated cell sorting (Fig. 3B,  lanes 1 and 2) , only very low levels of Ig-␤ RNA were detected in the CD8 ϩ population (lane 2) and even less was detected in the CD4 ϩ population (lane 1). When monitored by hybridization at low numbers of PCR cycles, Ig-␤ RNA indeed was undetectable in these T cells (Fig. 3B Bottom) . By contrast, the 0 and I transcripts from the germ-line IgH locus were readily detected in mature T cells (Fig. 3B and data not shown) . Thus, our results support the identification of Ig-␤ as highly ''B lineage-specific'' at the level of mature cells. By contrast, unfractionated normal thymus populations with no significant B lineage contamination showed at least as much Ig-␤ expression as immunodeficient thymus populations (Fig. 3A, lanes 4 and 5) . Although there are non-T lineage and primitive cells in scid or RAG Ϫ thymus that might express Ig-␤, these are diluted Ϸ100ϫ in normal thymus. Thus, this result rules out the possibility that thymic Ig-␤ expression is restricted to a rare early or non-T lineage thymocyte type. The level of this expression in unfractionated normal thymus remains Ն9ϫ lower than in spleen (data not shown), explaining the lack of detection using other methods. Even so, Ig-␤ RNA continues to be expressed in cells before and after TCR surface expression, and in thymocytes of both TCR-␣␤ and TCR-␥␦ lineages, as shown by the similar levels of Ig-␤ RNA per cell in thymocytes from normal, TCR␤ Delayed Repression: Shutoff of Ig-␤ Expression During Positive Selection. To ascertain whether Ig-␤ expression might be turned off at any stage of thymic development, normal C57BL͞6 thymocytes were fractionated to separate cells through different stages of positive selection and then analyzed for RNA expression (Fig. 4) . Two different sorting strategies were used to separate postselection intermediates between the CD4 ϩ CD8 (Fig. 4) . This expression pattern was confirmed by hybridization with an internal oligonucleotide probe (Fig. 4 D and E D and E) are autoradiograms of the hybridization of an internal probe to the Ig-␤ PCR products from these samples. Note that in E, the samples in lanes 5 (CD4 ϩ CD8 Ϫ CD69 Ϫ ) and 6 (CD4 ϩ CD8 Ϫ CD69 ϩ ) are reversed with respect to their order in development.
DISCUSSION
We have sought to define the progressive narrowing of developmental potential and the lineage commitment that occur during thymocyte differentiation (11, 12, (25) (26) (27) (28) in terms of discrete changes in gene expression. Our results show that T lineage specification and commitment actually involve a cascade of staggered gene regulatory events, not a single clean transition.
The activation of different T lineage "specific" genes begins asynchronously, with several of these genes turned on at stages that apparently precede T lineage commitment. Our data generally agree with previous results on the expression of particular genes in early thymocytes (37) (38) (39) (40) (41) , but the different onsets of expression of these genes are more sharply defined here than in previous studies. This is largely because of the sensitivity of RT-PCR, the simplified isolation of early subsets from immunodeficient thymocyte populations (13) Control of gene expression through this process is initially lineage-nonspecific, in that two transcripts controlled by the Ig-E enhancer also begin to be expressed in immature thymocytes. These transcripts are down-regulated just before the induction of recombinase activity, indicating a programmed, stage-specific repression mechanism. The role of this repression is underlined by the fact that mature T cells, which no longer express recombinase, appear to resume free expression of these two transcripts, in agreement with an extensive body of evidence for the activity of the E enhancer in later-stage thymocytes and mature T cells. The implication is that negative regulators, not positive regulators dependent on prior lineage commitment, may restrict IgH transcription specifically during one critical period when recombinase must choose between Ig and TCR gene targets.
This developmental gene expression program is still leaky enough to allow the sustained transcription of Ig-␤ until late stages of thymocyte maturation. There are other cases of apparent interlineage sharing of lymphocyte molecules, such as the expression of CD3 in fetal NK cells (42) , but this case adds emphasis to the phenomenon in several ways. The T and B lineage programs are more distinct than the NK and T lineages, yet thymocytes do not repress Ig-␤ until they have progressed far down this well marked developmental pathway, with any chance to differentiate as B cells left far behind. Also, unlike other, poorly characterized markers shared by B cells and thymocytes, e.g., ThB and HSA itself, Ig-␤ protein is a critical, cell-type-specific component of the B cell antigen receptor, which acts in early B cell precursors to trigger the initiation of V-DJh Ig gene rearrangements (43) . There is still a question of whether Ig-␤ is really B lineage-specific (note some expression of Ig-␤ in a heterogeneous, Gr-1 ϩ subset of fetal liver cells, Fig. 2 A) . Nevertheless, it achieves a highly B-specific pattern of expression in mature cells. Also, although Ig-␤ is one of the few B lineage genes that continues to be expressed in fetal liver cells of E2A knockout mice (44) , it appears to depend on B lineage-specific transcription factors, because it is not expressed in the developmentally arrested B220 ϩ marrow cells of EBF knockout mice (3). Thus, its expression has been viewed as an early, positive marker of B lineage specification or commitment. However, our data show that late T lineage-specific repression, not a requirement for B lineage-specific activating factors, restricts expression of this gene in T cells.
The permissiveness of thymocytes for expression of the ''early'' B cell gene, Ig-␤, contrasts with their lack of expression of the slightly ''later'' B cell genes, Ig-␣ and 5. This suggests that some positive transcription factors needed to drive expression of these ''late'' genes are excluded by T lineage differentiation, even though the factors that drive expression of Ig-␤ are not. Whatever the mechanism, this exclusion is temporally and mechanistically separate from the event in which the ''inappropriate'' Ig-␤ gene expression is repressed, later in differentiation. Thus, diverse negative as well as positive regulatory mechanisms are required.
Even if the Ig-␤ transcription does not result in any protein product, it is a valuable indicator of ''upstream'' regulatory events in thymocytes. The separate issue of whether low-level expression of Ig-␤ RNA confers any positive function on thymocytes remains to be determined. At a crude steady-state level, it is clear that major thymocyte populations are unchanged in Ig-␤ knockout mice (43) . On the other hand, if the Ig-␤ were expressed at the protein level, there is evidence that it could interact strongly with the CD3 complexes that are also present in thymocytes at early stages (45) . It is conceivable that such hybrid complexes could play a role in pre-T cell receptor function or the establishment of signaling thresholds for viability (46, 47) .
To prove a strict correlation between the regulation of various genes in the earliest stages of T cell differentiation and the establishment of developmental commitment, we will need to use single-cell methods. However, our present findings already show that the induction of genes associated with one lineage need not be rigidly linked with repression of genes associated with other potential lineages. Moreover, cells can make substantial progress activating T lineage-specific genes before they lose developmental plasticity and undergo commitment. At least some of this precocious expression appears to be multilineage. There are precedents for early multilineage gene expression, followed by lineage-specific repression, in erythromyeloid precursors (48, 49) . Other hematopoietic precursors provide evidence for transdifferentiation (50) . Now in the lymphoid case as well, both positive and negative gene regulatory mechanisms can be seen to contribute to lineage specificity, acting at different times. The stage is set now for identification of the lineage-specific transcription factors that are targets and executors of these mechanisms.
